BioCorRx Inc (BICX)
BioCorRx Inc. is a healthcare company listed on OTC Markets under the ticker BICX. Through its subsidiaries, the company develops and provides treatment programs in the United States for substance abuse and related disorders. Its offerings include Beat Addiction Recovery, a substance use disorder recovery program that combines cognitive behavioral therapy modules, peer support delivered through a mobile application, and medication prescribed by an independent physician. BioCorRx also provides UnCraveRx, a medication-assisted weight loss program with access to concierge on-demand wellness specialists. In addition, the company is developing several naltrexone-based product candidates, including BICX101, BICX102, and BICX104. BioCorRx licenses and distributes its programs to healthcare providers and licensed healthcare professionals. The company, founded in 2009 and based in Anaheim, California, adopted its current name in 2014.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BICX
|
$0.32
|
26.2% Upside
|
Undervalued
|
$0.80
|
220.0% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 17, 2026
|
-2.4x
|
-0.7x
|
9.6x
|
7.264 M
|
10.19 M
|
23.3%
|
64.5%
|
-120.6
|
—
|
59.5%
|
